Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24,883 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lung immune prognostic index is associated with clinical outcomes in recurrent or metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from the multicenter, single-arm, phase 2 study.
Min Y, Liu X, Wei Z, Song G, Li Y, Gao K, Liu Z, Pei Y, Li H, Ge J, Qing Y, Wei Y, Peng X. Min Y, et al. Among authors: wei y, wei z. Oral Oncol. 2024 Dec;159:107028. doi: 10.1016/j.oraloncology.2024.107028. Epub 2024 Sep 18. Oral Oncol. 2024. PMID: 39298831 Clinical Trial.
Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167).
Li Y, Min Y, Wei Z, Liu Z, Pei Y, Yang Y, Gao K, Song G, Xu S, He S, Ge J, Qing Y, Wei Y, Ai P, Chen Y, Peng X. Li Y, et al. Among authors: wei y, wei z. Cancer Immunol Immunother. 2025 Jan 3;74(2):72. doi: 10.1007/s00262-024-03905-0. Cancer Immunol Immunother. 2025. PMID: 39751901 Free PMC article. Clinical Trial.
24,883 results
You have reached the last available page of results. Please see the User Guide for more information.